Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Report 2026

Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview

• Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing market size has reached to $5.14 billion in 2025 • Expected to grow to $9.22 billion in 2030 at a compound annual growth rate (CAGR) of 12.3% • Growth Driver: Surge In Infectious Disease Cases Fueling The Growth Of The Market Due To Decline In Routine Immunization Coverage • Market Trend: Technological Advancements Driving mRNA Manufacturing Growth Due To Launch Of GMP-like Platforms For Preclinical Development • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?

Messenger ribonucleic acid (mRNA) synthesis and manufacturing is the biotechnological process of designing, producing, and purifying messenger RNA (mRNA) molecules at scale for use in therapeutics and vaccines. It involves transcribing synthetic DNA templates into mRNA using enzymatic reactions, followed by purification, formulation, and quality control to ensure the mRNA is stable, effective, and safe for clinical or commercial applications. The main types of messenger ribonucleic acid (mRNA) synthesis and manufacturing are messenger ribonucleic acid (mRNA) drug synthesis and messenger ribonucleic acid (mRNA) vaccine synthesis. Messenger ribonucleic acid (mRNA) drug synthesis refers to the laboratory and industrial processes involved in designing, synthesizing, and producing messenger ribonucleic acid (mRNA) sequences intended for therapeutic applications. The multiple scales of operation include preclinical, clinical, and commercial. The various therapeutic areas include infectious diseases, oncology, and others and cater to several applications such as vaccine production, therapeutic development, drug discovery, and others.

What Is The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Growth Forecast?

The messenger ribonucleic acid (mrna) synthesis and manufacturing market size is expected to see rapid growth in the next few years. It will grow to $9.22 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to technological advancements in automated mRNA synthesis, expansion of commercial-scale mRNA manufacturing facilities, rising investment in vaccine and therapeutic pipelines, increasing demand for self-amplifying mRNA and novel formulations, growth in preclinical and clinical research collaborations. Major trends in the forecast period include increasing adoption of gmp-compliant mrna synthesis, rising demand for large-scale mrna production, expansion of mrna therapeutics and vaccine pipelines, enhanced focus on purification capping and tailing services, growing integration of mrna-lnp formulations and stability testing.

Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Segmentation

1) By Service Type: Messenger Ribonucleic Acid (mRNA) Drug Synthesis, Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis 2) By Scale Of Operation: Preclinical, Clinical, Commercial 3) By Therapeutic Area: Infectious Diseases, Oncology, Other Therapeutic Areas 4) By Application: Vaccine Production, Therapeutic Development, Drug Discovery, Other Applications Subsegments: 1) By Messenger Ribonucleic Acid (mRNA) Drug Synthesis: Custom Messenger Ribonucleic Acid (mRNA) Synthesis, GMP-Grade Messenger Ribonucleic Acid (mRNA) Synthesis, Large-Scale Messenger Ribonucleic Acid (mRNA) Synthesis, Modified Messenger Ribonucleic Acid (mRNA) Synthesis, Capping And Tailing Services, Purification Services 2) By Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis: Preclinical Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, Clinical-Grade Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, GMP-Compliant Vaccine Batch Production, Self-Amplifying Messenger Ribonucleic Acid (mRNA) Synthesis, Messenger Ribonucleic Acid (mRNA)-LNP Formulation Services For Vaccines, Stability Testing And QC Services

What Is The Driver Of The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?

The increasing prevalence of infectious diseases is expected to propel the growth of the messenger ribonucleic acid (mRNA) synthesis and manufacturing market going forward. Infectious diseases refer to disorders caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, including diseases such as malaria that can spread directly or indirectly. The increasing prevalence of infectious diseases is due to rapid urbanization, which leads to higher population density and close human contact, facilitating the spread of infections. mRNA synthesis and manufacturing help combat infectious diseases by enabling the rapid development and scalable production of targeted vaccines and therapeutics that stimulate a specific immune response. For instance, in October 2024, according to the World Health Organization, a Switzerland-based international public health organization, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, up from about 7.5 million in 2022, placing tuberculosis as the leading infectious disease killer. Therefore, the increasing prevalence of infectious diseases is driving the growth of the messenger ribonucleic acid (mRNA) synthesis and manufacturing industry.

Key Players In The Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

Major companies operating in the messenger ribonucleic acid (mrna) synthesis and manufacturing market are Thermo Fisher Scientific Inc., Evonik Industries AG, Moderna Inc., BioNTech SE , AGC Biologics A/S, Eurofins Scientific SE, Lonza Group AG, Catalent Inc., WuXi Biologics (Cayman) Inc., Samsung Biologics Co Ltd., GenScript Biotech Corporation, Arcturus Therapeutics Holdings Inc., New England Biolabs Inc., CureVac N.V., Abzena plc, Creative Biolabs Inc., Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC

Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Trends and Insights

Major companies operating in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market are focusing on developing innovative products such as co-transcriptional capping platforms to accelerate preclinical research and reduce regulatory burden. A co-transcriptional capping platform is a proprietary method that efficiently attaches a protective cap to messenger ribonucleic acid (mRNA) molecules during synthesis, enhancing mRNA stability, translation efficiency, and immunogenicity control. For instance, in May 2025, GenScript, a US-based life sciences research tools company, launched its good manufacturing practice (GMP)-like messenger ribonucleic acid (mRNA) manufacturing service. It is a scalable, regulatory-aware manufacturing service developed to produce high-purity, functional mRNA for investigational new drug (IND)-enabling preclinical studies, including toxicology, biodistribution, and pharmacokinetics or pharmacodynamics (PK or PD) assessments. It is built upon cleanroom-compliant, International Organization for Standardization (ISO) 7-classified environments and incorporates patented co-transcriptional capping technology. This service delivers customized mRNA in as little as seven weeks. This innovation bridges the crucial development gap between research-grade and full GMP manufacturing, enabling early-stage biotechnology and pharmaceutical companies to conduct regulatory-aligned studies without the high costs and delays of traditional GMP production.

What Are Latest Mergers And Acquisitions In The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?

In June 2024, BioNTech, a Germany-based biotechnology company, acquired CureVac for an undisclosed amount. Through this acquisition, BioNTech aims to combine CureVac’s proprietary mRNA technology, RNA printer platform, and clinical pipeline with its own global infrastructure and development capabilities to strengthen its position in infectious diseases and oncology. CureVac is a Germany-based biopharmaceutical company that specializes in mRNA synthesis and manufacturing.

Regional Insights

North America was the largest region in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?

The messenger ribonucleic acid (mRNA) synthesis and manufacturing market consists of sales of synthetic deoxyribonucleic acid (DNA) templates, in vitro transcription kits, enzymes, nucleotides, purification systems, and formulation reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Report 2026?

The messenger ribonucleic acid (mrna) synthesis and manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the messenger ribonucleic acid (mrna) synthesis and manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.